Clinical Trials Directory

Trials / Completed

CompletedNCT00817791

Preconditioning With Hyperbaric Oxygen in Cardiovascular Surgery

Phase 1 Study of Protective Effect of Hyperbaric Oxygen Preconditioning on Brain and Myocardium Injury During CABG Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Xijing Hospital · Academic / Other
Sex
Male
Age
80 Years
Healthy volunteers
Not accepted

Summary

Animal studies have shown that preconditioning with hyperbaric oxygen can induce central nervous system and heart ischemic tolerance. This study was designed to determine the protective effect of hyperbaric oxygen preconditioning on brain and myocardium ischemia-reperfusion injury during coronary artery bypass graft surgery.

Detailed description

60 patients scheduled to undergo coronary revascularization were recruited for this trial. Exclusion criteria included Emergency operation, age older than 80 years, learning difficulty, previous cerebrovascular disease, visual or hearing impairment, history of pneumothorax, Claustrophobia, middle ear disease, EF \< 35%. Patients were randomized either to the control group or hyperbaric oxygen group. The laboratory analysis of markers included S100B, NSE and troponin I. The assessment of cognitive dysfunction was performed 5 days before surgery and 7 days after surgery and haemodynamic measurements, length of stay in ICU, length of stay in hospital post-operation were recorded.

Conditions

Interventions

TypeNameDescription
DEVICEHyperbaric oxygen pretreatment (GR2200)2 hours/day,5 days before surgery

Timeline

Start date
2007-11-01
Primary completion
2008-08-01
Completion
2009-03-01
First posted
2009-01-06
Last updated
2009-06-15

Source: ClinicalTrials.gov record NCT00817791. Inclusion in this directory is not an endorsement.